XML 29 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
 6 Months Ended 155 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (596,778) $ (1,358,613) $ (18,063,575)
Adjustments to reconcile net loss to net cash used in operating activities:      
Estimated fair value of contributed services 0 0 2,475,000
Gain on forgiveness of liabilities 0 (26,299) (116,213)
Amortization of prepaid consulting fees 0 53,866 807,608
Depreciation 338 528 3,154
Non-cash interest on notes payable 37,191 17,671 1,668,425
Stock-based compensation 112,364 346,188 2,049,027
Changes in assets and liabilities:      
Prepaid consulting costs 0 0 (140,000)
Prepaid expenses and other current assets (10,289) 36,494 (70,782)
Accounts payable 102,430 (532,509) 265,977
Accrued Phase Three expenses 0 (205,595) 111,871
Accrued expenses and payroll liabilities 48,835 121,110 144,666
Deferred revenue 20,000 0 100,000
NET CASH USED IN OPERATING ACTIVITIES (285,909) (1,547,159) (10,764,842)
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchases of fixed assets 0 0 (3,154)
NET CASH USED IN INVESTING ACTIVITIES 0 0 (3,154)
CASH FLOWS FROM FINANCING ACTIVITIES      
Proceeds from issuance of notes payable to stockholders 0 0 226,300
Proceeds from notes payable 0 1,000,000 2,500,000
Capital contributions 0 0 168,707
Net proceeds from purchase of common stock and exercise of warrants and stock options 0 0 99,450
Proceeds from Private Placements 0 0 7,779,092
NET CASH PROVIDED BY FINANCING ACTIVITIES 0 1,000,000 10,773,549
NET CHANGE IN CASH AND CASH EQUIVALENTS (285,909) (547,159) 5,553
CASH AND CASH EQUIVALENTS BALANCES, beginning of period 291,462 1,589,773 0
CASH AND CASH EQUIVALENTS BALANCES, end of period 5,553 1,042,614 5,553
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:      
Issuance of and adjustment to common stock and warrants to consulting firms for prepaid consulting fees 0 208,000 432,007
Conversion of notes payable and accrued interest into common stock 0 0 1,530,177
Forgiveness of notes payable and accrued interest to stockholders 0 0 241,701
Conversion of advances to notes payable to stockholders $ 0 $ 0 $ 196,300